|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income Loss | |||||
| Net income (loss) attributable to non-controlling interests | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities | |||||
| Net realized and unrealized (gains) losses | |||||
| Net (gain) loss on held for sale of business | |||||
| Non-cash compensation expense | |||||
| Amortization/accretion of premiums and discounts | |||||
| Depreciation and amortization expense | |||||
| Non-cash lease expense | |||||
| Deferred provision (benefit) for income taxes | |||||
| Amortization of deferred financing costs | |||||
| Change in fair value of liability classified warrants | |||||
| Other | |||||
| Net income from discontinued operations | |||||
| Changes in operating assets and liabilities: | |||||
| Mortgage loans originated for sale | |||||
| Proceeds from the sale of mortgage loans originated for sale | |||||
| (Increase) decrease in notes and accounts receivable | |||||
| (Increase) decrease in reinsurance recoverable | |||||
| (Increase) decrease in prepaid reinsurance premiums | |||||
| (Increase) decrease in deferred acquisition costs | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in unearned premiums | |||||
| Increase (decrease) in policy liabilities and unpaid claims | |||||
| Increase (decrease) in deferred revenue | |||||
| Increase (decrease) in reinsurance payable | |||||
| Increase (decrease) in other liabilities and accrued expenses | |||||
| Increase (decrease) in other liabilities and lease obligations | |||||
| Net cash provided by (used in) operating activities from continuing operations | |||||
| Net cash provided by (used in) operating activities from discontinued operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities: | |||||
| Purchases of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from the sale of businesses and other assets | |||||
| Proceeds from notes receivable | |||||
| Issuance of notes receivable | |||||
| Business and asset acquisitions, net of cash and deposits | |||||
| Net cash provided by (used in) investing activities from continuing operations | |||||
| Net cash provided by (used in) investing activities from discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities: | |||||
| Dividends paid | |||||
| Cash received for the exercise of warrants | |||||
| Non-controlling interest (redemptions) contributions | |||||
| Issuance of stock | |||||
| Fortegra common interests | |||||
| Fortegra preferred interests | |||||
| Issuance of warrants | |||||
| Fortegra Warrants | |||||
| Additional Warrants | |||||
| Payment of WP Transaction costs | |||||
| Cash (paid) received in connection with vested or exercised stock awards | |||||
| Payment of debt issuance costs | |||||
| Proceeds from borrowings and mortgage notes payable | |||||
| Principal paydowns of borrowings and mortgage notes payable | |||||
| Repurchases of common stock and other changes in additional paid-in capital | |||||
| Net cash provided by (used in) financing activities from continuing operations | |||||
| Net cash provided by (used in) financing activities from discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash – beginning of period | |||||
| Cash, cash equivalents and restricted cash - beginning of period - held for sale | |||||
| Cash, cash equivalents and restricted cash - end of period | |||||
| Less: Reclassification of cash to held for sale | |||||
| Cash, cash equivalents and restricted cash – end of period | |||||
| Supplemental Cash Flow Information | |||||
| Cash paid during the period for interest expense | |||||
| Cash (received) paid during the period for income taxes | |||||
| Supplemental Schedule of Non-Cash Investing and Financing Activities: | |||||
| Right of use asset obtained in exchange for lease liability | |||||
| Bonds and trade receivables exchanged for corporate loans and equity securities | |||||
| Shares issued in exchange for vested subsidiary awards | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...